 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Goate A. on PAPER: Larner AJ. et al., 2007, There is a three-generation history of LOAD in the family reported in this study. Only the... 3 Jan 2007.
|
|
|
 |
|
|
Goate A. on NEWS: APP Double Dose Causes Early-Onset AD, This is a very interesting paper that is totally consistent with the Aβ hypothesis. The... 20 Dec 2005.
|
|
|
|
|
|
Goate A. on PAPER: Lambert JC. et al., 2001, "Interesting paper showing an association between risk for AD and a polymorphism in the promoter... 29 Jun 2002.
|
|
|
|
|
|
Goate A. on PAPER: Zubenko GS. et al., 1998, Potential new risk factor for AD. No date saved.
|
|
|
|
|
|
Goate A. on PAPER: Sayi JG. et al., 1997, More data suggesting that APOE4 does not have a major impact on risk for ad among people of... No date saved.
|
|
|
|
|
|
Goate A. on PAPER: Tang MX. et al., 1998, Interesting paper highlighting differences in relative risk for ad associated with apoe4... No date saved.
|
|
|
|
|
|
Goate A. on PAPER: Zubenko GS. et al., 2001, This paper reports that the 234 bp allele of D10S1423 in conjunction with APOE4 is a strong... No date saved.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our latest Webinar: 
